Herceptin, as recognized, is for the treatment of early-stage breast cancer that is Human Epidermal growth factor Receptor 2-positive (HER2+) and has spread into the lymph nodes, or is HER2-positive and has not spread into the lymph nodes.


There are no reviews yet.

Be the first to review “Herceptin”

Your email address will not be published. Required fields are marked *